Sitagliptin Tiefenbacher 25 mg filmom obalené tablety Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin tiefenbacher 25 mg filmom obalené tablety

alfred e. tiefenbacher (gmbh & co. kg), nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Ansifora 50 mg filmom obalené tablety Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ansifora 50 mg filmom obalené tablety

vipharm s.a., poľsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin HCS 100 mg filmom obalené tablety Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin hcs 100 mg filmom obalené tablety

hcs bvba, belgicko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin HCS 50 mg filmom obalené tablety Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin hcs 50 mg filmom obalené tablety

hcs bvba, belgicko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin HCS 25 mg filmom obalené tablety Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin hcs 25 mg filmom obalené tablety

hcs bvba, belgicko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Onglyza European Union - Slovak - EMA (European Medicines Agency)

onglyza

astrazeneca ab - saxagliptin - diabetes mellitus, typ 2 - lieky používané pri cukrovke - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Starlix European Union - Slovak - EMA (European Medicines Agency)

starlix

novartis europharm limited - nateglinid - diabetes mellitus, typ 2 - lieky používané pri cukrovke - nateglinid je indikovaný pre kombinovanú liečbu s metformínom u pacientov s diabetom 2. typu, ktoré sú nedostatočne kontrolované napriek maximálnej tolerovanej dávke samotného metformínu.

Amaryl 2 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

amaryl 2 mg

sanofi winthrop industrie, francúzsko - glimepirid - 18 - antidiabetica (vrÁtane inzulÍnu)

Amaryl 3 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

amaryl 3 mg

sanofi winthrop industrie, francúzsko - glimepirid - 18 - antidiabetica (vrÁtane inzulÍnu)

Amaryl 4 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

amaryl 4 mg

sanofi winthrop industrie, francúzsko - glimepirid - 18 - antidiabetica (vrÁtane inzulÍnu)